ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,720.56
-0.61%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Zentalis Pharmaceuticals Inc (ZNTL)

  7. Zentalis Pharmaceuticals Inc (ZNTL) 뉴스

ZNTL Zentalis Pharmaceuticals Inc

11.06
0.075 (0.68%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Zentalis Pharmaceuticals Inc ZNTL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.075 0.68% 11.06 05:07:53
개장가 저가 고가 종가 전일 종가
11.10 10.77 11.23 11.06 10.985
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/04/202405:05GLOBEZentalis Pharmaceuticals to Highlight Preclinical Data..
02/04/202406:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
02/03/202408:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
01/03/202407:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/03/202407:14EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/02/202421:00GLOBEZentalis Pharmaceuticals to Participate in Upcoming Investor..
27/02/202421:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/02/202421:04EDGAR2Form 8-K - Current report
27/02/202421:00GLOBEZentalis Pharmaceuticals Reports Full Year 2023 Financial..
16/02/202406:12EDGAR2Form 8-K - Current report
14/02/202409:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202421:00GLOBEZentalis Pharmaceuticals to Participate in the Oppenheimer..
13/02/202410:25EDGAR2Form 144 - Report of proposed sale of securities
13/02/202410:25EDGAR2Form 144 - Report of proposed sale of securities
13/02/202410:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202409:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202409:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202409:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202409:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202411:29EDGAR2Form 144 - Report of proposed sale of securities
03/02/202411:29EDGAR2Form 144 - Report of proposed sale of securities
03/02/202411:28EDGAR2Form 144 - Report of proposed sale of securities
03/02/202411:27EDGAR2Form 144 - Report of proposed sale of securities
03/02/202411:26EDGAR2Form 144 - Report of proposed sale of securities
02/02/202407:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
25/01/202421:03EDGAR2Form 8-K - Current report
25/01/202421:00GLOBEZentalis Pharmaceuticals Strengthens Management Team with..
08/01/202421:03EDGAR2Form 8-K - Current report
08/01/202421:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
04/01/202410:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202410:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202406:49GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
22/12/202307:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202307:39GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
14/11/202307:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202307:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202321:00GLOBEZentalis to Participate in Investor Call Focused on Ovarian..
06/11/202323:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202323:04EDGAR2Form 8-K - Current report
06/11/202321:18GLOBEZentalis Pharmaceuticals Reports Third Quarter 2023..
02/11/202305:52GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
07/10/202308:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202308:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202308:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202306:00EDGAR2Form 8-K - Current report
05/10/202309:28EDGAR2Form 144 - Report of proposed sale of securities
05/10/202309:26EDGAR2Form 144 - Report of proposed sale of securities
05/10/202309:25EDGAR2Form 144 - Report of proposed sale of securities
03/10/202305:27GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
14/09/202305:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NASDAQ
ZNTL
Zentalis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유